Pipeline
We are an unparalleled biopharmaceutical company.
Biosimilars
- GS07In Market
-
MoleculeInfliximab
Reference DrugRemicade
IndicationAutoimmune Disease
- AP06Phase III
-
MoleculeTrastuzumab
Reference DrugHerceptin
IndicationBreast Cancer
- AP05Phase I
-
MoleculeRituximab
Reference DrugRituxan
IndicationLymphoma
- AP09Phase I
-
MoleculeAdalimumab
Reference DrugHumira
IndicationAutoimmune Disease
- About Us Privacy Policy Inquiries Sitemap
-
Company Infomation
Aprogen
545, Dunchon-daero, Jungwon-gu, Seongnam-si, Gyeonggi-do, Republic of Korea, 13215
Contact : +82-31-625-4045
-
Aprogen
545, Dunchon-daero, Jungwon-gu, Seongnam-si, Gyeonggi-do, Republic of Korea, 13215
Contact : +82-31-625-4045 - copyright(c) by APROGEN. All Right Reserved.